[The features of cancer-associated fibroblasts as components of tumor stroma in bladder cancer].
1/5 보강
The subject of the study is the data from the world literature on tumor-associated fibroblasts (CAF) and their target markers, on the relationship of this group of cells with clinical and prognostic c
APA
Sycheva IN, Oleynikova NA (2026). [The features of cancer-associated fibroblasts as components of tumor stroma in bladder cancer].. Arkhiv patologii, 88(2), 87-93. https://doi.org/10.17116/patol20268802187
MLA
Sycheva IN, et al.. "[The features of cancer-associated fibroblasts as components of tumor stroma in bladder cancer].." Arkhiv patologii, vol. 88, no. 2, 2026, pp. 87-93.
PMID
41989551 ↗
Abstract 한글 요약
The subject of the study is the data from the world literature on tumor-associated fibroblasts (CAF) and their target markers, on the relationship of this group of cells with clinical and prognostic characteristics. Tumor-associated fibroblasts are a heterogeneous group of cells of the mesenchymal microenvironment in the tumor stroma that play a significant role in tumor development and disease progression, and are also directly related to treatment tactics. Current trends in bladder cancer (BC) research include the investigation of these cell groups and their target markers. The following open internet resources were used to search for literature sources: PubMed, National Library of Medicine, and The Human Protein Atlas. Sources were selected using keywords (indicated in the appropriate field) and publication dates. CAFs and their immunohistochemical markers can be used not only to improve diagnostic panels of urothelial carcinomas, but also to potentially improve the selection criteria for patient groups for the application of various treatment strategies, including minimally invasive methods.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.